Human Reproductive Technologies Market Size, Trends, Analysis, and Outlook By Infertility Treatment (Drugs (Follitropin Alfa, Follitropin Beta, Menotropins), Devices (Sperm Separation Devices, Sperm Analyzer Systems, Ovum Aspiration Pumps, Micromanipulator Systems)), By Contraceptive (Drugs (Oral, Topical, Contraceptive), Devices (Condoms, IUD, Cervical Caps, Diaphragms)), By Gender (Male, Female), by Country, Segment, and Companies, 2024-2032
The global Human Reproductive Technologies market size is poised to register 4.8% growth from 2024 to 2032, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Human Reproductive Technologies market across By Infertility Treatment (Drugs (Follitropin Alfa, Follitropin Beta, Menotropins), Devices (Sperm Separation Devices, Sperm Analyzer Systems, Ovum Aspiration Pumps, Micromanipulator Systems)), By Contraceptive (Drugs (Oral, Topical, Contraceptive), Devices (Condoms, IUD, Cervical Caps, Diaphragms)), By Gender (Male, Female)
The Human Reproductive Technologies market is experiencing significant growth driven by the increasing prevalence of infertility, advancements in assisted reproductive techniques (ART), and expanding access to fertility treatments worldwide, enabling couples to overcome infertility challenges and achieve pregnancy. Human reproductive technologies encompass a range of fertility treatments, including in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), egg freezing, preimplantation genetic testing (PGT), and gamete donation, offering options for couples with male or female factor infertility, genetic disorders, or age-related fertility decline. The market is driven by demographic trends, including delaying childbearing, declining fertility rates, and societal acceptance of non-traditional family structures, as well as advancements in laboratory techniques, cryopreservation methods, and embryo selection algorithms that improve IVF success rates and patient outcomes. Further, the shift towards elective fertility preservation, LGBTQ+ family building, and personalized reproductive medicine is driving market expansion, as fertility clinics and reproductive endocrinologists offer tailored treatment options and supportive services. By 2030, the market is expected to witness further growth as stakeholders invest in ART innovation, patient-centric care models, and regulatory frameworks to ensure safe, effective, and equitable access to fertility treatments, addressing the evolving needs and preferences of individuals and couples seeking to build families.
Human Reproductive Technologies Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Human Reproductive Technologies market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Human Reproductive Technologies survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Human Reproductive Technologies industry.
Key market trends defining the global Human Reproductive Technologies demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
Human Reproductive Technologies Market Segmentation- Industry Share, Market Size, and Outlook to 2032
The Human Reproductive Technologies industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Human Reproductive Technologies companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the Human Reproductive Technologies industry
Leading Human Reproductive Technologies companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Human Reproductive Technologies companies.
Human Reproductive Technologies Market Study- Strategic Analysis Review
The Human Reproductive Technologies market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
The Human Reproductive Technologies industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2032 in three case scenarios- low case, reference case, and high case scenarios.
Human Reproductive Technologies Country Analysis and Revenue Outlook to 2032
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2032. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2032.
North America Human Reproductive Technologies Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong healthcare infrastructure. Leading companies focus on new product launches in the changing environment. The US healthcare expenditure is expected to grow to $4.8 trillion in 2024 (around 3.7% growth in 2024), potentially driving demand for various Human Reproductive Technologies market segments. Similarly, Strong market demand is encouraging Canadian Human Reproductive Technologies companies to invest in niche segments. Further, as Mexico continues to strengthen its relations and invest in technological advancements, the Mexico Human Reproductive Technologies market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe Human Reproductive Technologies Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European Human Reproductive Technologies industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of vendors in identifying and leveraging new growth prospects positions the European Human Reproductive Technologies market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific Human Reproductive Technologies Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Human Reproductive Technologies in Asia Pacific. In particular, China, India, and South East Asian Human Reproductive Technologies markets present a compelling outlook for 2032, acting as a magnet for both domestic and multinational vendors seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major countries in the APAC region.
Latin America Human Reproductive Technologies Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa Human Reproductive Technologies Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Human Reproductive Technologies market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Human Reproductive Technologies.
Human Reproductive Technologies Market Company Profiles
The global Human Reproductive Technologies market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are AbbVie Inc, Bayer AG, CooperSurgical Inc, Ferring B.V., Genea Ltd, Ivftech, Merck KGaA, Teva Pharmaceutical Industries.
Recent Human Reproductive Technologies Market Developments
The global Human Reproductive Technologies market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
Human Reproductive Technologies Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2032 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
By Infertility Treatment
Drugs
-Follitropin Alfa
-Follitropin Beta
-Menotropins
-Others
Devices
-Sperm Separation Devices
-Sperm Analyzer Systems
-Ovum Aspiration Pumps
-Micromanipulator Systems
-Others
By Contraceptive
Drugs
-Oral
-Topical
-Contraceptive
Devices
-Condoms
-IUD
-Cervical Caps
-Diaphragms
-Others
By Gender
Male
Female
Geographical Segmentation:
AbbVie Inc
Bayer AG
CooperSurgical Inc
Ferring B.V.
Genea Ltd
Ivftech
Merck KGaA
Teva Pharmaceutical Industries
Formats Available: Excel, PDF, and PPT
The Human Reproductive Technologies market is experiencing significant growth driven by the increasing prevalence of infertility, advancements in assisted reproductive techniques (ART), and expanding access to fertility treatments worldwide, enabling couples to overcome infertility challenges and achieve pregnancy. Human reproductive technologies encompass a range of fertility treatments, including in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), egg freezing, preimplantation genetic testing (PGT), and gamete donation, offering options for couples with male or female factor infertility, genetic disorders, or age-related fertility decline. The market is driven by demographic trends, including delaying childbearing, declining fertility rates, and societal acceptance of non-traditional family structures, as well as advancements in laboratory techniques, cryopreservation methods, and embryo selection algorithms that improve IVF success rates and patient outcomes. Further, the shift towards elective fertility preservation, LGBTQ+ family building, and personalized reproductive medicine is driving market expansion, as fertility clinics and reproductive endocrinologists offer tailored treatment options and supportive services. By 2030, the market is expected to witness further growth as stakeholders invest in ART innovation, patient-centric care models, and regulatory frameworks to ensure safe, effective, and equitable access to fertility treatments, addressing the evolving needs and preferences of individuals and couples seeking to build families.
Human Reproductive Technologies Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Human Reproductive Technologies market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Human Reproductive Technologies survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Human Reproductive Technologies industry.
Key market trends defining the global Human Reproductive Technologies demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
Human Reproductive Technologies Market Segmentation- Industry Share, Market Size, and Outlook to 2032
The Human Reproductive Technologies industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Human Reproductive Technologies companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the Human Reproductive Technologies industry
Leading Human Reproductive Technologies companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Human Reproductive Technologies companies.
Human Reproductive Technologies Market Study- Strategic Analysis Review
The Human Reproductive Technologies market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
- Industry Dynamics: Porter's Five Forces analysis to understand bargaining power, competitive rivalry, and threats that impact long-term strategy formulation.
- Strategic Insights: Provides valuable perspectives on key players and their approaches based on comprehensive strategy analysis.
- Internal Strengths and Weaknesses: Develop targeted strategies to leverage strengths, address weaknesses, and capitalize on market opportunities.
- Future Possibilities: Prepare for diverse outcomes with in-depth scenario analysis. Explore potential market disruptions, technology advancements, and economic changes.
The Human Reproductive Technologies industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2032 in three case scenarios- low case, reference case, and high case scenarios.
Human Reproductive Technologies Country Analysis and Revenue Outlook to 2032
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2032. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2032.
North America Human Reproductive Technologies Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong healthcare infrastructure. Leading companies focus on new product launches in the changing environment. The US healthcare expenditure is expected to grow to $4.8 trillion in 2024 (around 3.7% growth in 2024), potentially driving demand for various Human Reproductive Technologies market segments. Similarly, Strong market demand is encouraging Canadian Human Reproductive Technologies companies to invest in niche segments. Further, as Mexico continues to strengthen its relations and invest in technological advancements, the Mexico Human Reproductive Technologies market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe Human Reproductive Technologies Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European Human Reproductive Technologies industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of vendors in identifying and leveraging new growth prospects positions the European Human Reproductive Technologies market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific Human Reproductive Technologies Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Human Reproductive Technologies in Asia Pacific. In particular, China, India, and South East Asian Human Reproductive Technologies markets present a compelling outlook for 2032, acting as a magnet for both domestic and multinational vendors seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major countries in the APAC region.
Latin America Human Reproductive Technologies Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa Human Reproductive Technologies Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Human Reproductive Technologies market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Human Reproductive Technologies.
Human Reproductive Technologies Market Company Profiles
The global Human Reproductive Technologies market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are AbbVie Inc, Bayer AG, CooperSurgical Inc, Ferring B.V., Genea Ltd, Ivftech, Merck KGaA, Teva Pharmaceutical Industries.
Recent Human Reproductive Technologies Market Developments
The global Human Reproductive Technologies market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
Human Reproductive Technologies Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2032 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
- Pricing Analysis
- Value Chain Analysis
- SWOT Profile
- Market Dynamics- Trends, Drivers, Challenges
- Porter’s Five Forces Analysis
- Macroeconomic Impact Analysis
- Case Scenarios- Low, Base, High
By Infertility Treatment
Drugs
-Follitropin Alfa
-Follitropin Beta
-Menotropins
-Others
Devices
-Sperm Separation Devices
-Sperm Analyzer Systems
-Ovum Aspiration Pumps
-Micromanipulator Systems
-Others
By Contraceptive
Drugs
-Oral
-Topical
-Contraceptive
Devices
-Condoms
-IUD
-Cervical Caps
-Diaphragms
-Others
By Gender
Male
Female
Geographical Segmentation:
- North America (3 markets)
- Europe (6 markets)
- Asia Pacific (6 markets)
- Latin America (3 markets)
- Middle East Africa (5 markets)
AbbVie Inc
Bayer AG
CooperSurgical Inc
Ferring B.V.
Genea Ltd
Ivftech
Merck KGaA
Teva Pharmaceutical Industries
Formats Available: Excel, PDF, and PPT
1. EXECUTIVE SUMMARY
1.1 Human Reproductive Technologies Market Overview and Key Findings, 2024
1.2 Human Reproductive Technologies Market Size and Growth Outlook, 2021- 2030
1.3 Human Reproductive Technologies Market Growth Opportunities to 2030
1.4 Key Human Reproductive Technologies Market Trends and Challenges
1.4.1 Human Reproductive Technologies Market Drivers and Trends
1.4.2 Human Reproductive Technologies Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Human Reproductive Technologies Companies
2. HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE OUTLOOK TO 2030
2.1 Human Reproductive Technologies Market Size Outlook, USD Million, 2021- 2030
2.2 Human Reproductive Technologies Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. HUMAN REPRODUCTIVE TECHNOLOGIES MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Infertility Treatment
Drugs
-Follitropin Alfa
-Follitropin Beta
-Menotropins
-Others
Devices
-Sperm Separation Devices
-Sperm Analyzer Systems
-Ovum Aspiration Pumps
-Micromanipulator Systems
-Others
By Contraceptive
Drugs
-Oral
-Topical
-Contraceptive
Devices
-Condoms
-IUD
-Cervical Caps
-Diaphragms
-Others
By Gender
Male
Female
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific Human Reproductive Technologies Market, 2025
5.2 Asia Pacific Human Reproductive Technologies Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Human Reproductive Technologies Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Human Reproductive Technologies Market, 2025
5.5 Europe Human Reproductive Technologies Market Size Outlook by Type, 2021- 2030
5.6 Europe Human Reproductive Technologies Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Human Reproductive Technologies Market, 2025
5.8 North America Human Reproductive Technologies Market Size Outlook by Type, 2021- 2030
5.9 North America Human Reproductive Technologies Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Human Reproductive Technologies Market, 2025
5.11 South America Pacific Human Reproductive Technologies Market Size Outlook by Type, 2021- 2030
5.12 South America Human Reproductive Technologies Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Human Reproductive Technologies Market, 2025
5.14 Middle East Africa Human Reproductive Technologies Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Human Reproductive Technologies Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US Human Reproductive Technologies Market Size Outlook and Revenue Growth Forecasts
6.2 US Human Reproductive Technologies Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Human Reproductive Technologies Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Human Reproductive Technologies Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Human Reproductive Technologies Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Human Reproductive Technologies Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Human Reproductive Technologies Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Human Reproductive Technologies Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Human Reproductive Technologies Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Human Reproductive Technologies Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Human Reproductive Technologies Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Human Reproductive Technologies Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Human Reproductive Technologies Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Human Reproductive Technologies Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Human Reproductive Technologies Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Human Reproductive Technologies Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Human Reproductive Technologies Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Human Reproductive Technologies Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Human Reproductive Technologies Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Human Reproductive Technologies Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Human Reproductive Technologies Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Human Reproductive Technologies Industry Drivers and Opportunities
7. HUMAN REPRODUCTIVE TECHNOLOGIES MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. HUMAN REPRODUCTIVE TECHNOLOGIES COMPANY PROFILES
8.1 Profiles of Leading Human Reproductive Technologies Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
AbbVie Inc
Bayer AG
CooperSurgical Inc
Ferring B.V.
Genea Ltd
Ivftech
Merck KGaA
Teva Pharmaceutical Industries.
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
1.1 Human Reproductive Technologies Market Overview and Key Findings, 2024
1.2 Human Reproductive Technologies Market Size and Growth Outlook, 2021- 2030
1.3 Human Reproductive Technologies Market Growth Opportunities to 2030
1.4 Key Human Reproductive Technologies Market Trends and Challenges
1.4.1 Human Reproductive Technologies Market Drivers and Trends
1.4.2 Human Reproductive Technologies Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Human Reproductive Technologies Companies
2. HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE OUTLOOK TO 2030
2.1 Human Reproductive Technologies Market Size Outlook, USD Million, 2021- 2030
2.2 Human Reproductive Technologies Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. HUMAN REPRODUCTIVE TECHNOLOGIES MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Infertility Treatment
Drugs
-Follitropin Alfa
-Follitropin Beta
-Menotropins
-Others
Devices
-Sperm Separation Devices
-Sperm Analyzer Systems
-Ovum Aspiration Pumps
-Micromanipulator Systems
-Others
By Contraceptive
Drugs
-Oral
-Topical
-Contraceptive
Devices
-Condoms
-IUD
-Cervical Caps
-Diaphragms
-Others
By Gender
Male
Female
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific Human Reproductive Technologies Market, 2025
5.2 Asia Pacific Human Reproductive Technologies Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Human Reproductive Technologies Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Human Reproductive Technologies Market, 2025
5.5 Europe Human Reproductive Technologies Market Size Outlook by Type, 2021- 2030
5.6 Europe Human Reproductive Technologies Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Human Reproductive Technologies Market, 2025
5.8 North America Human Reproductive Technologies Market Size Outlook by Type, 2021- 2030
5.9 North America Human Reproductive Technologies Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Human Reproductive Technologies Market, 2025
5.11 South America Pacific Human Reproductive Technologies Market Size Outlook by Type, 2021- 2030
5.12 South America Human Reproductive Technologies Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Human Reproductive Technologies Market, 2025
5.14 Middle East Africa Human Reproductive Technologies Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Human Reproductive Technologies Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US Human Reproductive Technologies Market Size Outlook and Revenue Growth Forecasts
6.2 US Human Reproductive Technologies Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Human Reproductive Technologies Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Human Reproductive Technologies Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Human Reproductive Technologies Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Human Reproductive Technologies Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Human Reproductive Technologies Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Human Reproductive Technologies Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Human Reproductive Technologies Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Human Reproductive Technologies Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Human Reproductive Technologies Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Human Reproductive Technologies Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Human Reproductive Technologies Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Human Reproductive Technologies Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Human Reproductive Technologies Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Human Reproductive Technologies Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Human Reproductive Technologies Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Human Reproductive Technologies Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Human Reproductive Technologies Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Human Reproductive Technologies Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Human Reproductive Technologies Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Human Reproductive Technologies Industry Drivers and Opportunities
7. HUMAN REPRODUCTIVE TECHNOLOGIES MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. HUMAN REPRODUCTIVE TECHNOLOGIES COMPANY PROFILES
8.1 Profiles of Leading Human Reproductive Technologies Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
AbbVie Inc
Bayer AG
CooperSurgical Inc
Ferring B.V.
Genea Ltd
Ivftech
Merck KGaA
Teva Pharmaceutical Industries.
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
